BioNTech aims to start mRNA vaccine output in Rwanda in 2025
COVID-19 vaccine maker BioNTech aims to start production at its mRNA vaccine factory site in Rwanda in 2025, company officials said, the first foreign company mRNA vaccine manufacturing site on the continent. The German company's first modular factory elements, based on shipping containers, were delivered to the Kigali construction site in March and were then assembled into so-called BioNTainers. “Africa will have one of the most advanced manufacturing facilities in the world," Ugur Sahin, BioNTech co-founder and chief executive officer, said. "These BioNTainers will able to manufacture any kind of mRNA vaccines.” The company said in a statement it had fully…
